Conference Track

Treatment and Biomedical Prevention in Resource-Limited Settings

Source: CCO Official Conference Coverage of the 2008 International AIDS Conference

Capsule Summaries

Overestimation of Virologic Failure Resulting in Unnecessary Treatment Switches Associated With Use of WHO Criteria
Mortality in First Year of HAART Similar in Latin America, Caribbean as in Other Low-Income Countries
Botswana National HIV Treatment Program Reports Positive Effect on Survival When HAART Initiated at CD4+ Count > 100 cells/mm³
Review of Major Donor-Supported Antiretroviral Treatment Programs Notes Wide Variability in Outcome Indicators
Higher Complication Rate With BCG Vaccination in HIV-Infected Children in Argentina
Improved Survival Associated With HAART After TB Diagnosis
Triaging Patients With Low CD4+ Cell Counts to High-Contact Care Improves Survival Following Initiation of Antiretroviral Therapy in Kenyan Pilot Study
Universal Access to Antiretroviral Therapy Achieved in Rural Malawi District by Simple and Standardized Approach
Project HEART: Decentralization and Integration of Health Services in Sub-Saharan Africa Improves Access and Care to HIV-Infected Population
Circumcision Associated With Sustained Reduction in HIV Infection Risk Among Kenyan Men Through 3.5 Years in Kisumu Study

Expert Analysis

Treatment and Biomedical Prevention in Resource-Limited Settings

Faculty:

Richard E. Chaisson, MD
Elly Katabira, MD
Mauro Schechter, MD, PhD

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize new data on the successes and challenges of antiretroviral scale-up programs in resource-limited settings
Recount new findings on mortality among patients receiving HAART in resource-limited settings
Discuss recent data on the use of immunologic and clinical criteria to estimate virologic failure in resource-limited settings
Describe recent insights on tuberculosis coinfection and prevention in HIV-infected patients, including data on complications associated with Bacillus Calmette-Guérin vaccination in HIV-infected children
Recall data on HIV prevention in males by circumcision

CREDIT INFORMATION

Release Date: October 10, 2008

Expiration Date: October 09, 2009

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing contact hours

Pharmacists: 1.2 contact hours (0.12 CEUs)

Status: The activity is not currently available for credit.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.